Diaphorina citri psyllid: psy9323

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Octopamine receptor beta-1R	Receptor for octopamine. Octopamine (OA) is a neurotransmitter, neurohormone, and neuromodulator in invertebrates. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. Octopamine does not cause Ca(2+) release in oa2-expressing cells.	confident	Q9VCZ3

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0004989 [MF]	octopamine receptor activity	probable	GO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0035556 [BP]	intracellular signal transduction	probable	GO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0014070 [BP]	response to organic cyclic compound	probable	GO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0004993 [MF]	serotonin receptor activity	probable	GO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0044710 [BP]	single-organism metabolic process	probable	GO:0008150, GO:0008152
GO:0045664 [BP]	regulation of neuron differentiation	probable	GO:0030154, GO:0007275, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0050789, GO:0008150, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0051960, GO:2000026, GO:0048731
GO:0002029 [BP]	desensitization of G-protein coupled receptor protein signaling pathway	probable	GO:0048519, GO:0009968, GO:0009966, GO:0048585, GO:0023051, GO:0048583, GO:0008277, GO:0050794, GO:0008150, GO:0023057, GO:0045744, GO:0065007, GO:0010648, GO:0022401, GO:0048523, GO:0010646, GO:0050789, GO:0023058
GO:0007210 [BP]	serotonin receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0050789, GO:0044699
GO:0035625 [BP]	epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway	probable	GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0010647, GO:0048584, GO:0048583, GO:0042058, GO:0023056, GO:0031399, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:1901186, GO:1901184, GO:0010646, GO:0050789, GO:0044699, GO:0080090, GO:0051716, GO:0051347, GO:0045937, GO:0048522, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0045742, GO:0043085, GO:0044093, GO:0061097, GO:0061098, GO:0065007, GO:0065009, GO:0010469, GO:0048518, GO:2000273, GO:0045859, GO:0035624, GO:0060255, GO:0031323, GO:0045741, GO:0050794, GO:0051174, GO:0007176, GO:0032268, GO:0044763, GO:0007154, GO:0010604, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0050790, GO:0050731, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0031325, GO:0050730, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0032270
GO:0012505 [CC]	endomembrane system	probable	GO:0005575, GO:0044464, GO:0005623
GO:0007191 [BP]	adenylate cyclase-activating dopamine receptor signaling pathway	probable	GO:0065007, GO:0044700, GO:0051716, GO:0008150, GO:0007212, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0007189, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0007187, GO:0044699
GO:0007190 [BP]	activation of adenylate cyclase activity	probable	GO:0019220, GO:0031281, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:0051339, GO:0045981, GO:0043085, GO:0009893, GO:0030819, GO:0030816, GO:0045761, GO:0045762, GO:0009891, GO:0030810, GO:0050789, GO:0065007, GO:0044093, GO:0051349, GO:0048518, GO:0065009, GO:0045935, GO:0045937, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0051174, GO:1900542, GO:0008150, GO:0051171, GO:0051173, GO:0030799, GO:0031279, GO:1900544, GO:1900371, GO:0030808, GO:0080090, GO:0030804, GO:0030801, GO:1900373, GO:0030802, GO:0030817, GO:0006140, GO:0030814, GO:0010562, GO:0048522
GO:0007194 [BP]	negative regulation of adenylate cyclase activity	probable	GO:0010563, GO:0031280, GO:0080090, GO:0019222, GO:0031327, GO:0051350, GO:0031324, GO:0031323, GO:0009892, GO:1900371, GO:0045980, GO:0043086, GO:0019220, GO:0009890, GO:0030818, GO:0045761, GO:0030814, GO:0030815, GO:0050789, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0045934, GO:0045936, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0031326, GO:1900542, GO:0008150, GO:0051171, GO:0051172, GO:0030799, GO:0031279, GO:0051174, GO:1900543, GO:0030802, GO:0030809, GO:0030808, GO:1900372, GO:0030800, GO:0030803, GO:0051339, GO:0030817, GO:0006140, GO:0048523
GO:0042383 [CC]	sarcolemma	probable	GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886
GO:0050807 [BP]	regulation of synapse organization	probable	GO:0044700, GO:0019226, GO:0032501, GO:0044707, GO:0035637, GO:0050803, GO:0050877, GO:0009987, GO:0044763, GO:0050794, GO:0051128, GO:0065007, GO:0008150, GO:0023052, GO:0007268, GO:0007267, GO:0007154, GO:0065008, GO:0050789, GO:0044699, GO:0003008
GO:1901701 [BP]	cellular response to oxygen-containing compound	probable	GO:1901700, GO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0044763, GO:0070887, GO:0042221, GO:0044699
GO:0043197 [CC]	dendritic spine	probable	GO:0044309, GO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0010243 [BP]	response to organic nitrogen	probable	GO:0009719, GO:0050896, GO:1901698, GO:0008150, GO:0042221, GO:0010033
GO:0042803 [MF]	protein homodimerization activity	probable	GO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0004938 [MF]	alpha2-adrenergic receptor activity	probable	GO:0004930, GO:0004936, GO:0004935, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0038023, GO:0008227
GO:0045597 [BP]	positive regulation of cell differentiation	probable	GO:0051094, GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0005887 [CC]	integral to plasma membrane	probable	GO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224
GO:0042321 [BP]	negative regulation of circadian sleep/wake cycle, sleep	probable	GO:0048585, GO:0048583, GO:0007610, GO:0042745, GO:0050789, GO:0042749, GO:0051241, GO:0048511, GO:0048512, GO:0065007, GO:0048519, GO:0007623, GO:0007622, GO:0050795, GO:0042752, GO:0045187, GO:0008150, GO:0022410, GO:0051239, GO:0044708, GO:0050896, GO:0042754, GO:0048521
GO:0043025 [CC]	neuronal cell body	probable	GO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0008144 [MF]	drug binding	probable	GO:0003674, GO:0005488
GO:0051378 [MF]	serotonin binding	probable	GO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:0043176, GO:1901363
GO:0051379 [MF]	epinephrine binding	probable	GO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0032148 [BP]	activation of protein kinase B activity	probable	GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0031323, GO:0032147, GO:0045860, GO:0050789, GO:0043085, GO:0080090, GO:0051347, GO:0010604, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0033036 [BP]	macromolecule localization	probable	GO:0008150, GO:0051179
GO:0043235 [CC]	receptor complex	probable	GO:0043234, GO:0005575, GO:0032991
GO:0035240 [MF]	dopamine binding	probable	GO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:1901338
GO:0031090 [CC]	organelle membrane	probable	GO:0005575, GO:0016020, GO:0043227, GO:0043226, GO:0044422
GO:0051380 [MF]	norepinephrine binding	probable	GO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0045202 [CC]	synapse	probable	GO:0005575
GO:0044238 [BP]	primary metabolic process	probable	GO:0008150, GO:0008152
GO:0044446 [CC]	intracellular organelle part	probable	GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043226, GO:0044422
GO:0044444 [CC]	cytoplasmic part	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0005634 [CC]	nucleus	probable	GO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0001993 [BP]	regulation of systemic arterial blood pressure by norepinephrine-epinephrine	probable	GO:0003073, GO:0032501, GO:0044707, GO:0008015, GO:0003008, GO:0008150, GO:0003013, GO:0008217, GO:0065007, GO:0065008, GO:0044699, GO:0003044
GO:0043679 [CC]	axon terminus	probable	GO:0044306, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0043005, GO:0033267, GO:0042995
GO:0071883 [BP]	activation of MAPK activity by adrenergic receptor signaling pathway	probable	GO:0000187, GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0032147, GO:0023056, GO:0043406, GO:0043405, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0044699, GO:0043408, GO:0051716, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0043085, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0051174, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0071875, GO:0032268, GO:0044763, GO:0007154, GO:0065009, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0048522
GO:0044260 [BP]	cellular macromolecule metabolic process	probable	GO:0009987, GO:0044237, GO:0043170, GO:0071704, GO:0008150, GO:0008152
GO:0006898 [BP]	receptor-mediated endocytosis	probable	GO:0006897, GO:0016192, GO:0006810, GO:0008150, GO:0051234, GO:0051179
GO:0044057 [BP]	regulation of system process	probable	GO:0008150, GO:0065007, GO:0050789, GO:0051239
GO:0051240 [BP]	positive regulation of multicellular organismal process	probable	GO:0048518, GO:0008150, GO:0065007, GO:0050789, GO:0051239
GO:0043270 [BP]	positive regulation of ion transport	probable	GO:0051050, GO:0051049, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0051924 [BP]	regulation of calcium ion transport	probable	GO:0051049, GO:0010959, GO:0065007, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0004952 [MF]	dopamine neurotransmitter receptor activity	probable	GO:0004930, GO:0030594, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0071310 [BP]	cellular response to organic substance	probable	GO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0051482 [BP]	elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway	probable	GO:0050801, GO:0042592, GO:0023052, GO:0007165, GO:0007166, GO:0050789, GO:0044699, GO:0072507, GO:0051716, GO:0072503, GO:0065007, GO:0065008, GO:0007186, GO:0019725, GO:0006875, GO:0006874, GO:0009987, GO:0006873, GO:0050794, GO:0044763, GO:0030003, GO:0055065, GO:0055080, GO:0007154, GO:0055082, GO:0044700, GO:0051480, GO:0007200, GO:0050896, GO:0007204, GO:0048878, GO:0008150, GO:0055074
GO:0051130 [BP]	positive regulation of cellular component organization	probable	GO:0051128, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction